• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆细胞样膀胱癌:一例罕见病例报告。

Plasmacytoid bladder cancer: a rare case report.

作者信息

Benabdallah Wajdi, Ben Othmane Mouna, Ouahchi Ines, Mestiri Sarra, Belkacem Oussama, Bouassida Khaireddine, Hmida Wissem, Jaidane Mehdi

机构信息

Urology Department.

Department of Cytogenetic and Reproductive Biology, Farhat Hached University Teaching Hospital, Sousse, Tunisia.

出版信息

Ann Med Surg (Lond). 2023 Apr 11;85(5):1885-1887. doi: 10.1097/MS9.0000000000000374. eCollection 2023 May.

DOI:10.1097/MS9.0000000000000374
PMID:37228940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10205280/
Abstract

UNLABELLED

Plasmacytoid carcinoma of the bladder is a rare histological variant of urothelial carcinoma associated with late presentation. This pattern of disease may portend an extremely poor prognosis and significant challenges for treatment with curative intent.

CASE PRESENTATION

The authors report a case of a patient with locally advanced plasmacytoid urothelial carcinoma (PUC) of the bladder. A 71-year-old man with a history of chronic obstructive pulmonary disease presented with gross hematuria. The rectal examination revealed a fixed bladder base. A computed tomography scan showed a pedunculated lesion arising from the anterior and left lateral bladder wall and extended to the perivesical fat. The patient underwent transurethral resection of the tumor. The histologic examination revealed the presence of muscle-invasive PUC of the bladder. The decision of the multidisciplinary consultation meeting was to do palliative chemotherapy. Thus, the patient could not receive systemic chemotherapy and died 6 weeks after transurethral resection of the bladder tumor.

CLINICAL DISCUSSION

A plasmacytoid variant of urothelial carcinoma is a rare subtype of urothelial carcinoma that has a poor prognosis with a high mortality rate. The disease is usually diagnosed at an advanced stage. Given the rarity of plasmacytoid bladder cancer, treatment guidelines are not clear; therefore, more aggressive treatment may be required.

CONCLUSION

PUC of the bladder is characterized by high aggressiveness, an advanced stage at the time of diagnosis, and a poor prognosis.

摘要

未标注

膀胱浆细胞样癌是尿路上皮癌的一种罕见组织学变异型,与疾病晚期表现相关。这种疾病模式可能预示预后极差,且根治性治疗面临重大挑战。

病例报告

作者报告一例膀胱局部晚期浆细胞样尿路上皮癌(PUC)患者。一名有慢性阻塞性肺疾病病史的71岁男性因肉眼血尿就诊。直肠指检发现膀胱底部固定。计算机断层扫描显示一个带蒂病变,起源于膀胱前壁和左侧壁,并延伸至膀胱周围脂肪。患者接受了经尿道肿瘤切除术。组织学检查显示为膀胱肌层浸润性PUC。多学科会诊会议决定进行姑息化疗。因此,患者无法接受全身化疗,在经尿道膀胱肿瘤切除术后6周死亡。

临床讨论

尿路上皮癌的浆细胞样变异型是尿路上皮癌的一种罕见亚型,预后差,死亡率高。该疾病通常在晚期才被诊断出来。鉴于浆细胞样膀胱癌罕见,治疗指南尚不明确;因此,可能需要更积极的治疗。

结论

膀胱PUC具有侵袭性高、诊断时处于晚期以及预后差的特点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f8/10205280/136bbcf11569/ms9-85-1885-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f8/10205280/08e2a93c9b46/ms9-85-1885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f8/10205280/136bbcf11569/ms9-85-1885-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f8/10205280/08e2a93c9b46/ms9-85-1885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f8/10205280/136bbcf11569/ms9-85-1885-g002.jpg

相似文献

1
Plasmacytoid bladder cancer: a rare case report.浆细胞样膀胱癌:一例罕见病例报告。
Ann Med Surg (Lond). 2023 Apr 11;85(5):1885-1887. doi: 10.1097/MS9.0000000000000374. eCollection 2023 May.
2
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.膀胱浆细胞样尿路上皮癌:一项临床病理研究及文献综述
Int J Clin Exp Pathol. 2012;5(6):601-8. Epub 2012 Jul 29.
3
Plasmacytoid urothelial carcinoma of the bladder metastatic to the stomach: a case report.膀胱浆细胞样尿路上皮癌转移至胃:一例报告
Case Rep Urol. 2012;2012:715951. doi: 10.1155/2012/715951. Epub 2012 Aug 16.
4
Plasmacytoid urothelial carcinoma of the bladder.膀胱浆细胞样尿路上皮癌
Indian J Pathol Microbiol. 2014 Apr-Jun;57(2):320-2. doi: 10.4103/0377-4929.134730.
5
Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis.基因组分析后浆细胞样变异型膀胱癌对帕博利珠单抗的病理完全缓解
IJU Case Rep. 2022 May 9;5(4):304-307. doi: 10.1002/iju5.12463. eCollection 2022 Jul.
6
Plasmacytoid Variant Urothelial Cell Carcinoma: A Case of a Histological Variant of Urinary Bladder Cancer With Aggressive Behavior.浆细胞样变异型尿路上皮癌:1例具有侵袭性生物学行为的膀胱组织学变异型癌病例
Cureus. 2023 Mar 17;15(3):e36278. doi: 10.7759/cureus.36278. eCollection 2023 Mar.
7
Plasmacytoid Urothelial Carcinoma of Ureter with Retroperitoneal Metastasis: A Case Report.输尿管浆细胞样尿路上皮癌伴腹膜后转移:一例报告
Am J Case Rep. 2018 Feb 13;19:158-162. doi: 10.12659/ajcr.906679.
8
[A Case of PT1 Plasmacytoid Variant Bladder Cancer Treated by Bladder Conserving Therapy].[1例采用保膀胱治疗的PT1浆细胞样变异型膀胱癌病例]
Hinyokika Kiyo. 2018 Sep;64(9):369-372. doi: 10.14989/ActaUrolJap_64_9_369.
9
A rare case of plasmacytoid urothelial carcinoma of bladder: Diagnostic dilemmas and clinical implications.一例罕见的膀胱浆细胞样尿路上皮癌:诊断困境与临床意义
Indian J Urol. 2011 Jan;27(1):144-6. doi: 10.4103/0970-1591.78409.
10
Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma.尿路上皮癌浆细胞样变体导致的不良预后
Case Rep Oncol. 2022 Mar 31;15(1):369-375. doi: 10.1159/000524038. eCollection 2022 Jan-Apr.

本文引用的文献

1
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes.浆细胞样尿路上皮癌:对化疗的反应及肿瘤学结局
Bladder Cancer. 2020;6(1):71-81. doi: 10.3233/blc-190258. Epub 2020 Mar 28.
2
The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.SCARE 2020 指南:更新共识手术病例报告(SCARE)指南。
Int J Surg. 2020 Dec;84:226-230. doi: 10.1016/j.ijsu.2020.10.034. Epub 2020 Nov 9.
3
Metastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.
携带有 CDH-1 突变且产生高水平 CA 19-9 的转移性浆细胞性膀胱癌。病例报告及文献复习。
Am J Case Rep. 2020 Jul 9;21:e923130. doi: 10.12659/AJCR.923130.
4
Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes.膀胱浆细胞样变异型尿路上皮癌:临床病理特征和生存结局的系统评价和荟萃分析。
J Urol. 2020 Aug;204(2):215-223. doi: 10.1097/JU.0000000000000794. Epub 2020 Jan 31.
5
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review.膀胱癌的尿路上皮和非尿路上皮组织学变异对肌层浸润性和转移性膀胱癌患者的肿瘤学结局的预测价值及临床重要性如何?欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南小组系统评价。
Eur Urol Oncol. 2019 Nov;2(6):625-642. doi: 10.1016/j.euo.2019.09.003. Epub 2019 Oct 8.
6
Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.浆细胞样尿路上皮癌(PUC):影像学特征与组织病理学相关性
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E50-E57. doi: 10.5489/cuaj.3789. Epub 2017 Jan 12.
7
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.浆母细胞性尿路上皮癌,一种化疗敏感但预后差的癌症,伴腹膜转移。
J Urol. 2013 May;189(5):1656-61. doi: 10.1016/j.juro.2012.11.084. Epub 2012 Nov 15.